LivaNova (LIVN) EPS (Basic) (2014 - 2026)

LivaNova (LIVN) posted EPS (Basic) of $0.42 for Q1 2026, down 25.33% sequentially from $0.57 in Q4 2025, and up 107.04% YoY from $0.2 in Q1 2025.

LivaNova (LIVN) EPS (Basic) (2014 - 2026) Analysis & Trends

LivaNova has reported EPS (Basic) for 12 years, with the latest figure at $0.42 in Q1 2026.

Quarterly EPS (Basic) rose 107.04% year-over-year to $0.42 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.98 (up 148.39% YoY) and the FY2025 annual result came in at -$4.44, down 481.1% from the prior year.
EPS (Basic) slipped to $0.42 in Q1 2026 per LIVN's latest filing, from $0.57 in the prior quarter.
Over five years, EPS (Basic) peaked at $1.03 in Q4 2024 and troughed at -$6.01 in Q1 2025.
A 5-year average of -$0.24 and a median of $0.3 in 2024 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2024 and 2025: EPS (Basic) surged 1272.0% in 2024, then slumped 674.91% in 2025.
Over 5 years, EPS (Basic) stood at $0.03 in 2022, then jumped by 859.43% to $0.3 in 2023, then surged by 239.82% to $1.03 in 2024, then slumped by 45.0% to $0.57 in 2025, then decreased by 25.33% to $0.42 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered $0.42, $0.57, and $0.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.18 Bn	194.58 Bn	7.27 Bn	0.53
2	Stryker	129.87 Bn	126.39 Bn	4.50 Bn	3.33
3	Medtronic	120.25 Bn	111.03 Bn	6.41 Bn	0.98
4	Boston Scientific	73.97 Bn	73.43 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.73 Bn	48.48 Bn	1.35 Bn	0.42
6	Dexcom	34.66 Bn	32.71 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.17 Bn	32.06 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.51 Bn	23.19 Bn	4.55 Bn	0.65
9	Steris	23.24 Bn	22.75 Bn	684.20 Mn	2.06
10	LivaNova	4.36 Bn	3.84 Bn	273.67 Mn	1.98

Download Data